AVERY DURBIN: Open Payments
NPI 1538855283 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 21 payments from 10 companies in 2025. Trend: 2023 $219 · 2024 $670 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $163 |
| ABBVIE INC. | 2 | $49 |
| Novo Nordisk Inc | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: AIRSUPRA, VRAYLAR, JARDIANCE, TRELEGY ELLIPTA, NURTEC ODT, TZIELD, Wegovy, FARXIGA.
Industry payments across GA — which companies pay providers there.
